Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830771) titled 'Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis' on Sept. 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: University of Pennsylvania
Condition:
Tuberculosis, Pulmonary
Intervention:
Drug: [18F]-FAPI-74
Recruitment Status: Recruiting
Phase: Early Phase 1
Date of First Enrollment: September 30, 2026
Target Sample Size: 10
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07830771
Published by HT Digital ...